HIV and Antiretroviral Therapy (ART)

Standard antiretroviral therapy (ART) consists of the combination of antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. ART also prevents onward transmission of HIV. Huge reductions have been seen in rates of death and infections when use is made of a potent ARV regimen, particularly in early stages of the disease. WHO recommends ART for all people with HIV as soon as possible after diagnosis without any restrictions of CD4 counts? It also recommends offer of pre-exposure prophylaxis to people at substantial risk of HIV infection as an additional prevention choice as part of comprehensive prevention.

    Related Conference of HIV and Antiretroviral Therapy (ART)

    October 24-25, 2022

    17th World Congress on Virology, Emerging Diseases & Vaccines

    Zurich, Switzerland
    November 08-09, 2022

    7th Rare Diseases and Orphan Drugs

    London, UK
    November 21-22, 2022

    World Summit on Rare Disease

    Rome, Italy
    December 12-13, 2022

    5th Pathology and Infectious Disease Conference

    Prague, Czech Republic
    January 23-24, 2023

    10th International Congress on Infectious Diseases

    Barcelona, Spain
    February 20-21, 2023

    6th International Conference on Rare Diseases

    Amsterdam, Netherlands
    August 08-09, 2023

    19th World Congress on Infection Prevention and Control

    Zurich, Switzerland

    HIV and Antiretroviral Therapy (ART) Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in